HMCRX
Price
$14.56
Change
-$0.48 (-3.19%)
Updated
Dec 18 closing price
VIMAX
Price
$327.44
Change
-$11.29 (-3.33%)
Updated
Dec 18 closing price
Ad is loading...

HMCRX vs VIMAX

Header iconHMCRX vs VIMAX Comparison
Open Charts HMCRX vs VIMAXBanner chart's image
Harbor Mid Cap Retirement
Price$14.56
Change-$0.48 (-3.19%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$327.44
Change-$11.29 (-3.33%)
VolumeN/A
CapitalizationN/A
HMCRX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HMCRX vs. VIMAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HMCRX is a StrongBuy and VIMAX is a Buy.

FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 190B vs. HMCRX (176M). VIMAX pays higher dividends than HMCRX: VIMAX (1.49) vs HMCRX (0.59). HMCRX was incepted earlier than VIMAX: HMCRX (5 years) vs VIMAX (23 years). HMCRX is a more actively managed with annual turnover of: 19.00 vs. VIMAX (13.00). VIMAX has a lower initial minimum investment than HMCRX: VIMAX (3000) vs HMCRX (1000000). VIMAX annual gain was more profitable for investors over the last year : 17.87 vs. HMCRX (9.37). VIMAX return over 5 years is better than : 54.81 vs. HMCRX (47.61).
HMCRXVIMAXHMCRX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years23 years-
Gain YTD9.78117.82955%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets176M190B0%
Annual Yield % from dividends0.591.4939%
Returns for 1 year9.3717.8752%
Returns for 3 years3.0711.3727%
Returns for 5 years47.6154.8187%
Returns for 10 yearsN/A125.53-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SSKN3.040.05
+1.63%
Strata Skin Sciences
BLND5.04-0.02
-0.40%
Blend Labs
TER128.01-1.47
-1.14%
Teradyne
INZY2.94-0.08
-2.65%
Inozyme Pharma
LITE88.92-4.26
-4.57%
Lumentum Holdings